The gene expression data of prostate cancer (PRAD) patients in The Cancer Genome Atlas (TCGA) cohort suggested a moderate positive correlation (r = 0.22; p = 5.7 × 10−8) between HIF1A and CPT1A expression (Figure S4). This evidence concerns the gene CPT1A and prostate adenocarcinoma.